Does the state still frame debates about new technology? Can
policy-makers ensure the benefits of health developments through
genomics while still satisfying the expectations of society and the
economic imperatives? In this critique of the new governance agenda
for research and innovation in life sciences, the authors discuss
the world-wide policy decisions needed, with particular reference
to genomics. They suggest the many facets of policy and could be
treated as a government-governance continuum, where different
aspects of genomics may sit at different points, and co-exist.
Their findings offer valuable insights for the future and will help
promote a global solution to this problem.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!